Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?

Russo, RIC; Chervo, MF; Madera, S; Charreau, EH; Elizalde, PV

Russo, RIC; Elizalde, PV (reprint author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, Lab Mol Mech Carcinogenesis, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.

HORMONES & CANCER, 2019; 10 (2-3): 64

Abstract

Membrane overexpression of ErbB-2 (MErbB-2), a member of the ErbB family of receptor tyrosine kinases, occurs in 15-20% of breast cancers (BC) and con......

Full Text Link